Galey D - Search Results

1

Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases.

Conant K, St Hillaire C, Anderson C, Galey D, Wang J, Nath A. Conant K, et al. Among authors: galey d. J Neurovirol. 2004 Feb;10(1):21-8. doi: 10.1080/13550280490261699. J Neurovirol. 2004. PMID: 14982725

2

Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes.

Galey D, Becker K, Haughey N, Kalehua A, Taub D, Woodward J, Mattson MP, Nath A. Galey D, et al. J Neurovirol. 2003 Jun;9(3):358-71. doi: 10.1080/13550280390201119. J Neurovirol. 2003. PMID: 12775419

3

Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism.

Rumbaugh J, Turchan-Cholewo J, Galey D, St Hillaire C, Anderson C, Conant K, Nath A. Rumbaugh J, et al. Among authors: galey d. FASEB J. 2006 Aug;20(10):1736-8. doi: 10.1096/fj.05-5619fje. Epub 2006 Jun 28. FASEB J. 2006. PMID: 16807369

4

The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load.

Caporello E, Nath A, Slevin J, Galey D, Hamilton G, Williams L, Steiner JP, Haughey NJ. Caporello E, et al. Among authors: galey d. J Neurochem. 2006 Jul;98(1):146-55. doi: 10.1111/j.1471-4159.2006.03863.x. J Neurochem. 2006. PMID: 16805804 Free article.

5

Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046.

Steiner JP, Galey D, Haughey NJ, Asch D, Nath A. Steiner JP, et al. Among authors: galey d. J Neuroimmune Pharmacol. 2007 Mar;2(1):49-57. doi: 10.1007/s11481-006-9060-0. Epub 2007 Jan 3. J Neuroimmune Pharmacol. 2007. PMID: 18040826

6

Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Berger JR, Chauhan A, Galey D, Nath A. Berger JR, et al. Among authors: galey d. J Neurovirol. 2001 Aug;7(4):329-38. doi: 10.1080/13550280152537193. J Neurovirol. 2001. PMID: 11517412 Review. No abstract available.

7

Molecular and cellular mechanisms of neuronal cell death in HIV dementia.

Li W, Galey D, Mattson MP, Nath A. Li W, et al. Among authors: galey d. Neurotox Res. 2005 Oct;8(1-2):119-34. doi: 10.1007/BF03033824. Neurotox Res. 2005. PMID: 16260390 Review.

8

Selective isolation and purification of tat protein via affinity membrane separation.

Hollman AM, Christian DA, Ray PD, Galey D, Turchan J, Nath A, Bhattacharyya D. Hollman AM, et al. Among authors: galey d. Biotechnol Prog. 2005 Mar-Apr;21(2):451-9. doi: 10.1021/bp049804z. Biotechnol Prog. 2005. PMID: 15801785

9

HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant.

Patel J, Galey D, Jones J, Ray P, Woodward JG, Nath A, Mumper RJ. Patel J, et al. Among authors: galey d. Vaccine. 2006 Apr 24;24(17):3564-73. doi: 10.1016/j.vaccine.2006.01.065. Epub 2006 Feb 17. Vaccine. 2006. PMID: 16516358

10

Morphine self-administration into the lateral septum depends on dopaminergic mechanisms: Evidence from pharmacology and Fos neuroimaging.

Le Merrer J, Gavello-Baudy S, Galey D, Cazala P. Le Merrer J, et al. Among authors: galey d. Behav Brain Res. 2007 Jun 18;180(2):203-17. doi: 10.1016/j.bbr.2007.03.014. Epub 2007 Mar 16. Behav Brain Res. 2007. PMID: 17467070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters